Latest filings (excl ownership)
8-K
Bankruptcy or Receivership
28 Feb 24
25-NSE
Exchange delisting
15 Feb 24
8-K
Other Events
12 Dec 23
424B3
Prospectus supplement
22 Nov 23
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Nov 23
8-K
Changes in Registrant's Certifying Accountant
25 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
13 Oct 23
DEFA14A
Additional proxy soliciting materials
10 Oct 23
8-K
Departure of Directors or Certain Officers
6 Oct 23
8-K
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
29 Sep 23
EFFECT
Notice of effectiveness
26 Sep 23
EFFECT
Notice of effectiveness
26 Sep 23
S-1/A
IPO registration (amended)
21 Sep 23
S-3/A
Shelf registration (amended)
21 Sep 23
CORRESP
Correspondence with SEC
21 Sep 23
CORRESP
Correspondence with SEC
21 Sep 23
UPLOAD
Letter from SEC
13 Sep 23
DEF 14A
Definitive proxy
7 Sep 23
DEFA14A
Additional proxy soliciting materials
7 Sep 23
8-K/A
Financial Statements and Exhibits
7 Sep 23
S-1
IPO registration
5 Sep 23
DEFA14A
Additional proxy soliciting materials
5 Sep 23
8-K
Entry into a Material Definitive Agreement
5 Sep 23
PRER14A
Preliminary revised proxy
25 Aug 23
8-K
Entry into a Material Definitive Agreement
25 Aug 23
8-K
Material Modifications to Rights of Security Holders
24 Aug 23
8-A12G
Registration of securities
24 Aug 23
DEFA14A
Additional proxy soliciting materials
21 Aug 23
8-K
Entry into a Material Definitive Agreement
21 Aug 23
424B5
Prospectus supplement for primary offering
18 Aug 23
424B3
Prospectus supplement
17 Aug 23
8-K
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
16 Aug 23
10-Q
2023 Q2
Quarterly report
16 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
DEFA14A
Additional proxy soliciting materials
9 Aug 23
8-K/A
Other Events
9 Aug 23
DEFA14A
Additional proxy soliciting materials
31 Jul 23
8-K/A
Entry into a Material Definitive Agreement
31 Jul 23
Latest ownership filings
SC 13G/A
BLACK HORSE CAPITAL LP
14 Feb 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
3
Natalie McAndrew
11 Oct 23
3
Yong Chan Kim
13 Jul 23
SC 13G/A
BLACK HORSE CAPITAL LP
10 Jul 23
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G/A
INTRACOASTAL CAPITAL, LLC
8 Feb 23
4
GERALDINE HENWOOD
19 Dec 22
SC 13G
INTRACOASTAL CAPITAL, LLC
6 Sep 22
4
William Ashton
17 Jun 22
4
Arnold M Baskies
17 Jun 22
4
WINSTON J CHURCHILL
17 Jun 22
4
Andrew T Drechsler
17 Jun 22
4
Jillian Dilmore
17 Jun 22
4
GERALDINE HENWOOD
17 Jun 22
4
Wayne Weisman
17 Jun 22
SC 13G
INTRACOASTAL CAPITAL, LLC
27 May 22
3
Jillian Dilmore
26 Apr 22
SC 13G/A
ARMISTICE CAPITAL, LLC
15 Feb 22
SC 13G
INTRACOASTAL CAPITAL, LLC
6 Jan 22
4
GERALDINE HENWOOD
23 Dec 21
4
GERALDINE HENWOOD
14 Dec 21
4
GERALDINE HENWOOD
23 Sep 21
4
WINSTON J CHURCHILL
31 Aug 21
4
Richard S Casten
23 Aug 21
4
WINSTON J CHURCHILL
8 Jun 21
4
Richard S Casten
17 May 21
4
Arnold M Baskies
13 May 21
4
GERALDINE HENWOOD
10 May 21
4
Arnold M Baskies
8 Apr 21
4
Wayne Weisman
8 Apr 21
4
Andrew T Drechsler
8 Apr 21
4
WINSTON J CHURCHILL
8 Apr 21
4
William Ashton
8 Apr 21
4
ALFRED ALTOMARI
8 Apr 21
4
Richard S Casten
16 Mar 21
4
Richard S Casten
10 Mar 21
3
Richard S Casten
10 Mar 21
SC 13G
ARMISTICE CAPITAL, LLC
16 Feb 21
SC 13G
CORSAIR CAPITAL MANAGEMENT, L.P.
16 Feb 21